Caspofungin: A Review of its Use in Oesophageal Candidiasis, Invasive Candidiasis and Invasive Aspergillosis

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.20, 2003-01, pp. : 2235-2263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Micafungin: A Review of its Use in Adults for the Treatment of Invasive and Oesophageal Candidiasis, and as Prophylaxis Against Candida Infections

By Cross Sarah A. Scott Lesley J.

Drugs, Vol. 68, Iss. 15, 2008-01 ,pp. : 2225-2255

Adis International

Access to resources Recommend Favorite

Invasive Oesophageal Candidiasis: Current and Developing Treatment Options

By Vazquez J.A.

Drugs, Vol. 63, Iss. 10, 2003-01 ,pp. : 971-989

Adis International

Access to resources Recommend Favorite

Caspofungin is effective and well-tolerated in neonates with refractory invasive candidiasis

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Caspofungin: Development of resistance during treatment for invasive candidiasis, resulting in fatal multiple organ failure: case report

Reactions Weekly, Vol. 1, Iss. 1229, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Micafungin appears to be cost saving versus caspofungin when used to treat candidaemia and invasive candidiasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 589, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite